REFERENCE
1. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis
and management. Clin Infect Dis 44(5):705-710, 2007.
2. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis:
current concepts and review of the literature. J Am Coll Surg
208(2):279-288, 2009.
3. Grimaldi D, Bonacorsi S, Roussel H, et al. Unusual “flesh-eating”
strain of Escherichia coli. J Clin Microbiol 48(10):3794-3796, 2010.
4. Gallois C, Hauw-Berlemont C, Richaud C, Bonacorsi S, Diehl JL,
Mainardi JL. Fatal necrotizing fasciitis due to necrotic toxin-producing
Escherichia coli strain. In: New Microbes New Infect 8:109-112, 2015.
5. Bucca K, Spencer R, Orford N, Cattigan C, Athan E, McDonald A. Early
diagnosis and treatment of necrotizing fasciitis can improve survival:
an observational intensive care unit cohort study. ANZ J Surg
83(5):365-370, 2013.
6. Hadeed GJ, Smith J, O’Keeffe T, et al. Early surgical intervention
and its impact on patients presenting with necrotizing soft tissue
infections: A single academic center experience. J Emerg Trauma Shock
9(1):22-27, 2016.
7. Foreman MG, Mannino DM, Moss M. Cirrhosis as a risk factor for sepsis
and death: analysis of the National Hospital Discharge Survey. Chest
124(3):1016-1020, 2003.
8. Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and
infections in patients with cirrhosis. Clin Gastroenterol Hepatol
9(9):727-738, 2011.
9. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M.
Population structure, virulence potential and antibiotic susceptibility
of uropathogenic Escherichia coli from Northwest England. J Antimicrob
Chemother 67(2):346-356, 2012.
10. Banerjee R, Johnston B, Lohse C, et al. The clonal distribution and
diversity of extraintestinal Escherichia coli isolates vary according to
patient characteristics. Antimicrob Agents Chemother 57(12):5912-5917,
2013.
11. Ward DV, Scholz M, Zolfo M, et al. Metagenomic sequencing with
strain-level resolution implicates uropathogenic E. coli in
necrotizing enterocolitis and mortality in preterm infants. Cell
Rep 14(12):2912-2924, 2016.
12. Ciesielczuk H, Jenkins C, Chattaway M, et al. Trends in ExPEC
serogroups in the UK and their significance. Eur J Clin Microbiol Infect
Dis 35(10):1661-1666, 2016.
13. Ranjan A, Shaik S, Nandanwar N, et al. Comparative genomics of
Escherichia coli isolated from skin and soft tissue and
other extraintestinal infections. mBio 8(4), 2017.
14. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, O’Brien AD.
Cytotoxic necrotizing factor type 1-positive Escherichia coli causes
increased inflammation and tissue damage to the prostate in a rat
prostatitis model. Infect Immun 69(10):6515-6519, 2001.
15. Rippere-Lampe KE, O’Brien AD, Conran R, Lockman HA. Mutation of the
gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates
the virulence of uropathogenic Escherichia coli. Infect Immun
69(6):3954-3964, 2001.
16. Gall-Mas L, Fabbri A, Namini MRJ, Givskov M, Fiorentini C,
Krejsgaard T. The bacterial toxin CNF1 induces activation and maturation
of human monocyte-derived dendritic cells. Int J Mol Sci 19(5), 2018.